Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test Post published:April 6, 2021 Post category:Press Release
Tryp Therapeutics Announces Listing on OTCQB and DTC Eligibility Post published:April 5, 2021 Post category:Press Release
MindMed Announces the Publication of New Data on Personalized MDMA Dosing Post published:April 5, 2021 Post category:Press Release
Psychedelic Bulletin: UCSF Launches Psychedelics Division; New Additions to the Psychedelics ETF; Massachusetts City Decriminalizes Psychedelics Post published:April 2, 2021 Post category:Psychedelic Bulletin
Tryp Therapeutics Announces Amendment to Option Plan and Option Grant Post published:April 2, 2021 Post category:Press Release
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors Post published:April 1, 2021 Post category:Press Release
Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer Post published:April 1, 2021 Post category:Press Release
Lobe Sciences Becomes Enterprise Member of NFL Alumni Association Post published:March 31, 2021 Post category:Press Release
Wesana Health Announces Closing of C$16.1 Million Oversubscribed Private Placement Post published:March 31, 2021 Post category:Press Release
MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients Post published:March 31, 2021 Post category:Press Release